Essentials of Atrial Fibrillation
Please note that the standard 14-day cancellation right terminates upon receiving access to the e-book.
Product description
This handbook offers timely investigation of current pharmaceutical trends, clinical guidelines, novel treatments, and ongoing pipeline developments, including ground-breaking advances in the use of novel oral anticoagulants. Atrial fibrillation (AF) affects an estimated 1–2% of the population and is the most common cause of sustained cardiac arrhythmia. Critically, the number of patients developing AF is expected to double in the next five decades, leading to increased incidence of stroke, heart failure and other serious thromboembolic events.
Accessibility information
Select variation, to see accessibility information
Details
- ISBN13 9781907673986
- Released 2014
- Publisher Springer Healthcare
- Language English